A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
- 2017-08-30
- Observational · n = 68
- BMC complementary and alternative medicine 17(1)
- Angèle Guilbot
- Marie Bangratz
- Samira Ait Abdellah
- Christian Lucas
- PubMed: 28854909
- DOI: 10.1186/s12906-017-1933-7
- Moderate evidence
- Clinical
The proportion of patients with anxiety and depressive symptoms (Hospital Anxiety and Depression Scale) decreased between baseline phase and third month of supplementation from 52.4% (33/63) to 30% (18/60) for anxiety.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 112.5 mg/day